Pharmaceutical compositions useful as vaccines are described containing a purified surface or excreted protein qualitatively or quantitatively associated with a type of cancer at least one interleukin (IL) and at least one colony stimulating factor (CSF) where the purified surface or excreted protein is provided in an amount sufficient to induce an immune response in an individual administered the composition. Such compositions can be used in methods for treating individuals having cancer and for inducing an immunotherapeutic response in the same.
